Asthma and COVID‐19: Is asthma a risk factor for severe outcomes?
Gespeichert in:
| Veröffentlicht in: | Allergy (Copenhagen) 2020-07, Vol.75 (7), p.1543-1545 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1545 |
|---|---|
| container_issue | 7 |
| container_start_page | 1543 |
| container_title | Allergy (Copenhagen) |
| container_volume | 75 |
| creator | Johnston, Sebastian L. |
| description | |
| doi_str_mv | 10.1111/all.14348 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7267381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2397661420</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4718-e68febf8a26f441b78105e54049fef64b5c2adc4efc52a560e0ed8c3fb282323</originalsourceid><addsrcrecordid>eNp1kctKJDEUhoM4aHtZ-AJS4EYXpblWJS6Upp1LQ4MbcRtS6RMtrapoUqW48xHmGedJjNOtqOCBcBbn4-MPP0I7BB-SNEemaQ4JZ1yuoBFhSuZKKbGKRphgkXPB5DraiPEGY1xShdfQOqNMSKX4CE3Gsb9uTWa6eTY5v5ye_Xv-S9RxNo2ZWV6yUMfbzBnb-5C59CI8QIDMD731LcTTLfTDmSbC9nJvootfPy8mf_LZ-e_pZDzLLS-JzKGQDionDS0c56QqZYoHgmOuHLiCV8JSM7ccnBXUiAIDhrm0zFVU0pR4E50stHdD1cLcQtcH0-i7ULcmPGlvav350tXX-so_6JIWJZMkCfaXguDvB4i9butooWlMB36ImjJVFgXhFCd07wt644fQpd9pyinlTPDiVXiwoGzwMQZw72EI1q_N6NSM_t9MYnc_pn8n36pIwNECeKwbePrepMez2UL5ArIzl2o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2422435461</pqid></control><display><type>article</type><title>Asthma and COVID‐19: Is asthma a risk factor for severe outcomes?</title><source>Wiley-Blackwell Journals</source><source>Wiley-Blackwell Open Access Backfiles</source><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>Johnston, Sebastian L.</creator><creatorcontrib>Johnston, Sebastian L.</creatorcontrib><identifier>ISSN: 0105-4538</identifier><identifier>EISSN: 1398-9995</identifier><identifier>DOI: 10.1111/all.14348</identifier><identifier>PMID: 32358994</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Asthma ; Asthma - drug therapy ; Asthma - epidemiology ; Asthma - immunology ; Azithromycin - therapeutic use ; Betacoronavirus ; Comorbidity ; Coronavirus Infections - drug therapy ; Coronavirus Infections - epidemiology ; Coronavirus Infections - virology ; COVID-19 ; COVID-19 Drug Treatment ; Humans ; Immunity, Innate ; Pandemics ; Pneumonia, Viral - drug therapy ; Pneumonia, Viral - epidemiology ; Pneumonia, Viral - virology ; Risk Factors ; SARS-CoV-2 ; Steroids - therapeutic use ; Treatment Outcome</subject><ispartof>Allergy (Copenhagen), 2020-07, Vol.75 (7), p.1543-1545</ispartof><rights>2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.</rights><rights>Copyright © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4718-e68febf8a26f441b78105e54049fef64b5c2adc4efc52a560e0ed8c3fb282323</citedby><cites>FETCH-LOGICAL-c4718-e68febf8a26f441b78105e54049fef64b5c2adc4efc52a560e0ed8c3fb282323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fall.14348$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fall.14348$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32358994$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Johnston, Sebastian L.</creatorcontrib><title>Asthma and COVID‐19: Is asthma a risk factor for severe outcomes?</title><title>Allergy (Copenhagen)</title><addtitle>Allergy</addtitle><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Asthma</subject><subject>Asthma - drug therapy</subject><subject>Asthma - epidemiology</subject><subject>Asthma - immunology</subject><subject>Azithromycin - therapeutic use</subject><subject>Betacoronavirus</subject><subject>Comorbidity</subject><subject>Coronavirus Infections - drug therapy</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Coronavirus Infections - virology</subject><subject>COVID-19</subject><subject>COVID-19 Drug Treatment</subject><subject>Humans</subject><subject>Immunity, Innate</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - drug therapy</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Pneumonia, Viral - virology</subject><subject>Risk Factors</subject><subject>SARS-CoV-2</subject><subject>Steroids - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0105-4538</issn><issn>1398-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctKJDEUhoM4aHtZ-AJS4EYXpblWJS6Upp1LQ4MbcRtS6RMtrapoUqW48xHmGedJjNOtqOCBcBbn4-MPP0I7BB-SNEemaQ4JZ1yuoBFhSuZKKbGKRphgkXPB5DraiPEGY1xShdfQOqNMSKX4CE3Gsb9uTWa6eTY5v5ye_Xv-S9RxNo2ZWV6yUMfbzBnb-5C59CI8QIDMD731LcTTLfTDmSbC9nJvootfPy8mf_LZ-e_pZDzLLS-JzKGQDionDS0c56QqZYoHgmOuHLiCV8JSM7ccnBXUiAIDhrm0zFVU0pR4E50stHdD1cLcQtcH0-i7ULcmPGlvav350tXX-so_6JIWJZMkCfaXguDvB4i9butooWlMB36ImjJVFgXhFCd07wt644fQpd9pyinlTPDiVXiwoGzwMQZw72EI1q_N6NSM_t9MYnc_pn8n36pIwNECeKwbePrepMez2UL5ArIzl2o</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Johnston, Sebastian L.</creator><general>Blackwell Publishing Ltd</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202007</creationdate><title>Asthma and COVID‐19: Is asthma a risk factor for severe outcomes?</title><author>Johnston, Sebastian L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4718-e68febf8a26f441b78105e54049fef64b5c2adc4efc52a560e0ed8c3fb282323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Asthma</topic><topic>Asthma - drug therapy</topic><topic>Asthma - epidemiology</topic><topic>Asthma - immunology</topic><topic>Azithromycin - therapeutic use</topic><topic>Betacoronavirus</topic><topic>Comorbidity</topic><topic>Coronavirus Infections - drug therapy</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Coronavirus Infections - virology</topic><topic>COVID-19</topic><topic>COVID-19 Drug Treatment</topic><topic>Humans</topic><topic>Immunity, Innate</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - drug therapy</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Pneumonia, Viral - virology</topic><topic>Risk Factors</topic><topic>SARS-CoV-2</topic><topic>Steroids - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johnston, Sebastian L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Allergy (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johnston, Sebastian L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Asthma and COVID‐19: Is asthma a risk factor for severe outcomes?</atitle><jtitle>Allergy (Copenhagen)</jtitle><addtitle>Allergy</addtitle><date>2020-07</date><risdate>2020</risdate><volume>75</volume><issue>7</issue><spage>1543</spage><epage>1545</epage><pages>1543-1545</pages><issn>0105-4538</issn><eissn>1398-9995</eissn><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>32358994</pmid><doi>10.1111/all.14348</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0105-4538 |
| ispartof | Allergy (Copenhagen), 2020-07, Vol.75 (7), p.1543-1545 |
| issn | 0105-4538 1398-9995 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7267381 |
| source | Wiley-Blackwell Journals; Wiley-Blackwell Open Access Backfiles; MEDLINE; EZB Electronic Journals Library |
| subjects | Anti-Bacterial Agents - therapeutic use Asthma Asthma - drug therapy Asthma - epidemiology Asthma - immunology Azithromycin - therapeutic use Betacoronavirus Comorbidity Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Coronavirus Infections - virology COVID-19 COVID-19 Drug Treatment Humans Immunity, Innate Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Pneumonia, Viral - virology Risk Factors SARS-CoV-2 Steroids - therapeutic use Treatment Outcome |
| title | Asthma and COVID‐19: Is asthma a risk factor for severe outcomes? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T09%3A16%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Asthma%20and%20COVID%E2%80%9019:%20Is%20asthma%20a%20risk%20factor%20for%20severe%20outcomes?&rft.jtitle=Allergy%20(Copenhagen)&rft.au=Johnston,%20Sebastian%20L.&rft.date=2020-07&rft.volume=75&rft.issue=7&rft.spage=1543&rft.epage=1545&rft.pages=1543-1545&rft.issn=0105-4538&rft.eissn=1398-9995&rft_id=info:doi/10.1111/all.14348&rft_dat=%3Cproquest_pubme%3E2397661420%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2422435461&rft_id=info:pmid/32358994&rfr_iscdi=true |